Analysis of prognostic factors on trifluridine-tipiracil plus bevacizumab treatment in metastatic colorectal cancer: A retrospective real-world analysis

被引：0
|
作者：
Onishi, M. [1 ]
Hirose, T. [1 ]
Shoji, H. [1 ]
Okita, N. T. [1 ]
Hirano, H. [1 ]
Takashima, A. [1 ]
Kato, K. [1 ]
机构：
[1] NCCH Natl Canc Ctr Hosp, Dept Gastrointestinal Med Oncol, Tsukiji Campus,Chuo Ku, Tokyo, Japan
来源：
ANNALS OF ONCOLOGY | 2024年 / 35卷
关键词：
D O I：
10.1016/j.annonc.2024.10.121
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
99P
引用
收藏
页码：S1441 / S1441
页数：1
相关论文
共 50 条
  • [21] Efficacy and safety of trifluridine/tipiracil plus bevacizumab and trifluridine/tipiracil or regorafenib monotherapy for chemorefractory metastatic colorectal cancer: a retrospective study
    Chida, Keigo
    Kotani, Daisuke
    Nakamura, Yoshiaki
    Kawazoe, Akihito
    Kuboki, Yasutoshi
    Shitara, Kohei
    Kojima, Takashi
    Taniguchi, Hiroya
    Watanabe, Jun
    Endo, Itaru
    Yoshino, Takayuki
    THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY, 2021, 13
  • [22] Real-world use of trifluridine/tipiracil for patients with metastatic colorectal cancer in Canada
    Samawi, H. H.
    Brezden-Masley, C.
    Afzal, A. R.
    Cheung, W. Y.
    Dolley, A.
    CURRENT ONCOLOGY, 2019, 26 (05) : 319 - +
  • [23] Retrospective cohort study of trifluridine/tipiracil (TAS-102) plus bevacizumab versus trifluridine/tipiracil monotherapy for metastatic colorectal cancer
    Kotani, Daisuke
    Kuboki, Yasutoshi
    Horasawa, Satoshi
    Kaneko, Asumi
    Nakamura, Yoshiaki
    Kawazoe, Akihito
    Bando, Hideaki
    Taniguchi, Hiroya
    Shitara, Kohei
    Kojima, Takashi
    Tsuji, Akihito
    Yoshino, Takayuki
    BMC CANCER, 2019, 19 (01)
  • [24] Impact of KRAS codon-specific mutations on survival of patients with metastatic CRC (mCRC) treated with trifluridine-tipiracil (TAS) plus bevacizumab (Bev): A real-world analysis
    Maddalena, Giulia
    van der Pol, Ymke
    Rivers, Zachary
    Dasari, Arvind
    Rogers, Jane E.
    Guinney, Justin
    Kopetz, Scott
    Raghav, Kanwal Pratap Singh
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (3_SUPPL) : 201 - 201
  • [25] Efficacy and safety of trifluridine/tipiracil plus bevacizumab versus trifluridine/tipiracil monotherapy for refractory metastatic colorectal cancer: a retrospective cohort study
    Li, Rong-Rong
    Zhou, Hui-Jun
    Zeng, De-Yu
    Jiang, Shao-Feng
    Liu, Wu
    Fruehling, Petter
    Liu, Zhen-Yang
    JOURNAL OF GASTROINTESTINAL ONCOLOGY, 2024, 15 (02) : 612 - 629
  • [26] Retrospective cohort study of trifluridine/tipiracil (TAS-102) plus bevacizumab versus trifluridine/tipiracil monotherapy for metastatic colorectal cancer
    Daisuke Kotani
    Yasutoshi Kuboki
    Satoshi Horasawa
    Asumi Kaneko
    Yoshiaki Nakamura
    Akihito Kawazoe
    Hideaki Bando
    Hiroya Taniguchi
    Kohei Shitara
    Takashi Kojima
    Akihito Tsuji
    Takayuki Yoshino
    BMC Cancer, 19
  • [27] Real-world experience on the efficacy and tolerability of biweekly trifluridine/tipiracil with or without bevacizumab in metastatic colorectal cancer.
    Ang, Choon Seong
    Low, Qin Jian
    Ho, Carol Lf
    Walsh, Robert John
    Asokumaran, Yugarajah
    Choo, Joan Re
    Chan, Gloria Hj
    Ho, Jingshan
    Ang, Yvonne
    Tan, Hon Lyn
    Yong, Wei-Peng
    Sundar, Raghav
    Chee, Cheng Ean
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)
  • [28] Survival analysis based on the grade of neutropenia in patients with metastatic colorectal cancer treated with trifluridine-tipiracil
    Avino Tarazona, V.
    Rodriguez Garces, M.
    Amor Urbano, M.
    Bolanos Naranjo, M.
    ANNALS OF ONCOLOGY, 2021, 32 : S140 - S140
  • [29] Predictive and prognostic impact of primary tumor location on sequential treatment with regorafenib and trifluridine/tipiracil at third line and beyond in metastatic colorectal cancer: A real-world multicenter retrospective analysis
    Signorelli, C.
    Calegari, M. A.
    Basso, M.
    Anghelone, A.
    Lucchetti, J.
    Minelli, A.
    Angotti, L.
    Zurlo, I. V.
    Schirripa, M.
    Chilelli, M. G.
    Morelli, C.
    Dell'Aquila, E.
    Gemma, D.
    Ribelli, M.
    Arrivi, G.
    Zoratto, F.
    Morandi, M. G.
    Santamaria, F.
    Saltarelli, R.
    Ruggeri, E. M.
    ANNALS OF ONCOLOGY, 2023, 34 : S442 - S443
  • [30] Real-world experience with trifluridine/tipiracil on metastatic colorectal cancer in a third level hospital
    Rosero Rodriguez, D.
    Perez de Aguado, P.
    Chamorro Perez, J.
    Albarran Fernandez, V.
    Longo, F.
    Reguera Puertas, P.
    Delfrade, M.
    Fuentes Mateos, R.
    Guillen-Ponce, C.
    Lopez Gomez, V.
    Rodriguez Garrote, M.
    Vaz, M.
    Villamayor Delgado, M.
    Fernandez Fradejas, J.
    Garrido, P.
    Gil, M.
    Pozas, J.
    Gemeno Lopez, E.
    Sotoca Rubio, P.
    Alia Navarro, V.
    Barrill Corpa, A.
    Ferreiro Monteagudo, R.
    ANNALS OF ONCOLOGY, 2023, 34 : S84 - S84
12345